≥99% RP-HPLC Verified · All Lots 3rd Party Tested · ESI-MS COA Available · Every Lot Lyophilized · Sealed Vials RUO · USA TESTED Free Standard Shipping Over $300
≥99% RP-HPLC Verified ESI-MS Confirmed Lyophilized RUO

TH9507 / Ipamorelin Blend (6MG / 2MG) Analytical Reference Material (In Vitro Research Only)

$94.95

A two-peptide research blend of TH9507 (tesamorelin, a GHRH analog) and Ipamorelin. The two act on different pituitary receptors: TH9507 on the GHRH receptor and Ipamorelin on the ghrelin receptor (GHS-R1a). Published cell-culture work has studied each in endocrine cells. Each component is listed separately below.

Size

In stock

2:00 PM PST Same-Day Laboratory Dispatch · Free Shipping Over $300

1:1 Analytical & Chemical Specifications

Verified Physicochemical Properties & Lot Traceability for TH9507 / Ipamorelin Blend (6MG / 2MG)
Analytical Parameter Verified Specification
CAS Number TH9507 (Tesamorelin): 218949-48-5 | Ipamorelin: 170851-70-4
Molecular Formula TH9507 (Tesamorelin): C221H366N72O67S | Ipamorelin: C38H49N9O5
Molecular Weight TH9507 (Tesamorelin): 5135.90 g/mol | Ipamorelin: 711.86 g/mol
Amino Acid Sequence TH9507 (Tesamorelin) (6mg / 8mg): trans-hexenoyl-GRF(1-44)-NH2 | Ipamorelin (2mg): Aib-His-D-2Nal-D-Phe-Lys-NH2
Chromatographic Purity (RP-HPLC) >=99.0% Peak Area (Observed Lot 2026TESAIPA62A: 99.3%)
Identity Verification Electrospray Ionization Mass Spectrometry (ESI-MS)
Physical Form Lyophilized Powder in Sealed Desiccated Glass Vial
Recommended Storage -20°C Desiccated & Protected from Light
Regulatory Classification Research Use Only (RUO) — Not a 503A Compounding Pharmacy Product; Strictly Not for Human or Veterinary Use
Lot Traceability Lot 2026TESAIPA62A (Tested 2026-03-02) — Verify Dataset in COA Library →
Blend Component Breakdown
TH9507 (Tesamorelin) (6mg / 8mg)
MW: 5135.90 g/mol
CAS: 218949-48-5
Seq: trans-hexenoyl-GRF(1-44)-NH2
Ipamorelin (2mg)
MW: 711.86 g/mol
CAS: 170851-70-4
Seq: Aib-His-D-2Nal-D-Phe-Lys-NH2

Lot-Specific Certificate of Analysis (COA)

Lot: 2026TESAIPA62A · Tested:
Observed Purity 99.3% RP-HPLC (214 nm)
Observed Mass TH9507 (Tesamorelin): 5135.90 Da | Ipamorelin: 711.86 Da ESI-MS Identity
Retention Time 13.10 min C18 Gradient

In Vitro Laboratory Research Scope

Typical laboratory uses: studying how endocrine cell cultures respond when the GHRH receptor and the ghrelin receptor are engaged together. For in-vitro laboratory research only. Not for human or animal use.

Analytical Verification & Storage Parameters for TH9507 / Ipamorelin Blend

How is the chromatographic purity of TH9507 / Ipamorelin Blend (6MG / 2MG) verified?

Every production batch of TH9507 / Ipamorelin Blend (6MG / 2MG), including active Lot 2026TESAIPA62A, undergoes independent Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) with UV/Vis detection at 214 nm and Electrospray Ionization Mass Spectrometry (ESI-MS), confirming 99.3% peak area purity (retention time 13.10 min) and exact molecular mass concordance prior to catalog release.

What are the laboratory storage and stability parameters for lyophilized TH9507 / Ipamorelin Blend?

Lyophilized TH9507 / Ipamorelin Blend reference material is supplied in a sealed, desiccated borosilicate glass vial under inert atmosphere and must be stored at -20°C protected from light to prevent hydrolytic or oxidative cleavage. Once solubilized in sterile aqueous buffer for in vitro assays, maintain aliquots at 2°C to 8°C and avoid repeated freeze-thaw cycles.

What are the chemical identifiers and regulatory classification of TH9507 / Ipamorelin Blend?

TH9507 / Ipamorelin Blend is characterized by CAS Registry identifier TH9507 (Tesamorelin): 218949-48-5 | Ipamorelin: 170851-70-4, molecular formula TH9507 (Tesamorelin): C221H366N72O67S | Ipamorelin: C38H49N9O5, and theoretical molecular weight TH9507 (Tesamorelin): 5135.90 g/mol | Ipamorelin: 711.86 g/mol. Regenerative Health Peptides supplies this reagent strictly as a Research Use Only (RUO) analytical reference material for qualified 21+ in vitro laboratory investigations, never for human or veterinary use.

Primary Scientific Literature & Preclinical Citations

Peer-Reviewed

The following peer-reviewed scientific publications report preclinical investigations into the biochemical mechanisms and receptor pharmacology of this compound. Regenerative Health Peptides supplies this material strictly for in-vitro laboratory research.

Ferdinandi ES (2007) / Raun K (1998) · Basic Clin Pharmacol / Eur J Endocrinol
Model: In-vitro endocrine cell cultures
Finding: Dual engagement of distinct pituitary receptor families in in-vitro models

Laboratory Testing Guides & Documentation

View All Guides →
Done shopping?

Review your research compounds or proceed to checkout.

🔥 LIMITED TIME • BUY 2 GET 1 FREE
Buy 2 Get 1 FREE! Add 3 to cart
Use Code: 3for2